First drug for severe form of fatty liver disease approved March 15, 2024 Fatty liver disease, hepatic steatosis, NAFLD, NASH, liver cirrhosis, FDA approves Rezdiffra, Madrigal Pharmaceuticals, liver scarring, Nikolay Nikolov. Disease linked to obesity, high cholesterol, diabetes, alcohol abuse, with medication focusing on liver damage treatment. from LifeStyle - Latest Lifestyle News, Hot Trends, Celebrity Styles & Events https://ift.tt/wcGCB3Y https://ift.tt/Ystim9z Tweet Share Share Share Share Related Post